• KETRANEF TABLET

  KETRANEF TABLET

  KETRANEF SACHET

COMPOSITION:

Each film coated tablet contains Calcium-3-methyl-2-oxo-valerate 67 mg (a-Ketoanalogue to isoleucine calcium salt), Calcium-4-methyl-2-oxo-valerate 101 mg (a-Ketoanalogue to leucine calcium salt), Calcium-2-oxo-3-phenylpropionate 68 mg (a-Ketoanalogue to phenylalanine calcium salt), Calcium-3-methyl-2-oxo-butyrate 86 mg (a-Ketoanalogue to valine calcium salt), Calcium DL-2-Hydroxy-4 (methylthio) butyrate 59 mg (a-hydroxyanalogue to methionine calcium salt), L-Lysine Acetate 105 mg (eq. to L-Lysine 75 mg), L-Threonine 53 mg, L-Tryptophan 23 mg, L-Histidine 38 mg & L-Tyrosine 30 mg. Total Nitrogen content 36 mg & Calcium content 1.25 mmol = 0.05 g per Tablet

FORMULATION:

TABLETS

STATUS:

PRESCRIPTION ONLY DRUG

DESCRIPTION:

Ketranef Tablets contains Alpha-Ketoanalogue which is used in the treatment of chronic kidney disease. It works by preventing the unnecessary increase in urea levels in the blood due to the intake of non-essential amino acids in patients of kidney failure, thus improving renal function. It serves to eliminate the protein deficiency in CKD patients.

SIDE EFFECTS:

Increased calcium levels, nausea, vomiting, diarrhoea & abdominal pain.

DOSAGE/DIRECTIONS FOR USE:

As Prescribed by Physician.